Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan |
Flashes of Hope, McKenna Claire Foundation |
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children’s Research Hospital |
Tap Cancer Out |
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs |
University of Alberta |
Cure4Cam Childhood Cancer Foundation |
Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease |
St. Jude Children’s Research Hospital |
Northwestern Mutual Foundation |
Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis |
Duke University |
Tap Cancer Out |
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children’s Hospital of Chicago |
Tap Cancer Out |
Targeting symmetric division in pediatric cancers |
Dana-Farber Cancer Institute |
The Swifty Foundation |
Novel Genomic Drivers in Pediatric Polyposis Syndromes |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
ECM-targeted CAR T-cell therapy for high-grade glioma |
St. Jude Children’s Research Hospital |
Cure4Cam Childhood Cancer Foundation |
Targeted Hyperactivation of PI3K/AKT in B-cell malignancies |
Dana-Farber Cancer Institute |
Cure4Cam Childhood Cancer Foundation |